NAVIGNOSTICS International Trademark (WIPO) Information

On Thursday, February 15, 2024, an International Trademark registration was filed for NAVIGNOSTICS by Andrea Jacobs *********, **********, ***** ****. The World Intellectual Property Organization (WIPO) has given the trademark application number of 1789760. The expiration date for this trademark is 2/15/2034. The NAVIGNOSTICS trademark is filed in the description of Reactants for medical diagnosis; preparations for medical diagnosis; diagnostic reagents for medical or veterinary use in in vitro diagnosis; reactants for medical diagnosis, particularly for usage with spatial single-cell proteomics reagents for diagnostic tests for medical use; diagnostic test reagents for veterinary use; diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic substances for medical use; pharmaceutical products, medical and veterinary preparations; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations; pharmaceutical preparations for the diagnosis of diseases; pharmaceutical preparations for diagnosis; pharmaceutical preparations for diagnostic purposes; pharmaceutical preparations for individual medical diagnosis pharmaceutical preparations for medical test kits; pharmaceutical preparations for medical test kits for use in oncology; pharmaceutical preparations for medical test kits for cancer diagnosis; pharmaceutical preparations for medical test kits for individual medical diagnosis; diagnostic test kits diagnostic test kits for use in oncology; diagnostic test kits for cancer diagnosis; diagnostic test kits for individual medical diagnosis. , Apparatus for tumour diagnosis; medical apparatus for machine learning-based spectrum analysis of human blood plasma; scanners for medical diagnosis apparatus for clinical diagnosis spectrum analyzers for use in medical diagnosis trace material analyzers for medical use in diagnosis apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins medical test kits; diagnostic, examination, and monitoring equipment; medical tests kits for the use in oncology; medical test kits for cancer diagnosis; medical test kits for individual diagnosis. , Scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of proteomics; oncological research; research in the field of oncological diagnostics; computer programming for medical data analysis for cancer diagnostics; development of personalized diagnostics products for cancer treatment; software-as-a-service [SaaS] for use in cancer diagnosis; platform-as-a-service [PaaS] for use in cancer diagnosis; software-as-a-service [SaaS] for use in oncology; platform-as-a-service [PaaS] for use in oncology; software-as-a-service [SaaS] for medical and scientific research in the field of cancer treatment and diagnosis; platform-as-a-service [PaaS] for medical and scientific research in the field of cancer treatment and diagnosis; software-as-a-service [SaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; platform-as-a-service [PaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; computer programming in the field of using machine learning regarding medical diagnosis and research, particularly for cancer research, treatment and diagnosis; software as a service [SaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software-as-a-service [SaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis platform-as-a-service [PaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis software as-a-service [SaaS] for the digital representation of tumours and tumour features; platform-as-a-service [PaaS] for the digital representation of tumours and tumour features; software as-a-service [SaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies platform-as-a-service [PaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies software as-a-service [SaaS] for high-resolution digital image representation of digital tumors platform-as-a-service [PaaS] for high-resolution digital image representation of digital tumors; cancer diagnosis research. .